Issue of Fully Convertible Warrants

Date: 31/08/2026 Ref: WHL/BSE/-issue of Warrant / 31ST AUGUST/2026-27 Department of Corporate Services, BSE Ltd., Ground Floor, P.J Towers, Dalal Street, Fort, Mumbai – 400 001 Dear Sir(s), Ref: BSE Scrip Code: 512063 Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Issue of Warrants on Private Placement basis Dear Sir/Madam, This is to inform you that in pursuance to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time (‘SEBI LODR Regulations’) the Board of Directors of the Company in their meeting held today i.e., Monday, the 31st August, 2026 commenced at 7:45 p.m. and concluded at 8:50 p.m. has approved the proposal for issue of Warrants on Preferential Basis through Private Placement Up to 1,25,00,000 (One Crore Twenty-Five Lakh only) fully convertible warrants (“Warrants”) for cash at a price of ₹10/- per warrant (including the warrant subscription price and warrant exercise price) determined in accordance with the applicable provisions of Chapter V of SEBI (ICDR) Regulation 2018, each Warrant convertible into 1 (one) fully paid-up equity share of the Company of face value of ₹10 (Rupees Ten only) each issued at par, each aggregating up to ₹12,50,00,000 (Rupees Twelve Crore Fifty-Lakh Only) to the below-mentioned Proposed Allottees of the Company subject to approval of members of the Company and such other statutory and regulatory approvals as may be applicable: Sr No Name of the Proposed Category Pre-Preferential Issue No. of Convertible *Post Preferential Issue Allottees Warrants (Assuming conversion of proposed to be 1,25,00,000 convertible allotted Warrants into Equity Shares under present Preferential Issue) No. of % of share No. of Shares % of share Shares holding held holding held 1. Yatin Sanjay Gupte Promoter / 90,750 37.04 5200000 52,90,750 41.51 Promoter Group 2. Sheetal Mandar Bhalerao Promoter 34,760 14.19 1800000 18,34,760 14.40 /Promoter Group 3. Ram Chander Sharma Non-Promoter Nil Nil 2,00,000 2,00,000 1.57 Group 4. Nitu Sharma Non-Promoter Nil Nil 2,00,000 2,00,000 1.57 Group 5. Ram Chander Sharma HUF Non-Promoter Nil Nil 2,00,000 2,00,000 1.57 Group 6. Shyam Sunder Sharma Non-Promoter Nil Nil 2,00,000 2,00,000 1.57 Group 7. Hemlata Sharma Non-Promoter Nil Nil 2,00,000 2,00,000 1.57 Group 8. Shyam Sunder Sharma HUF Non-Promoter Nil Nil 2,00,000 200000 1.57 Group 9. Aakanksha Kabra Non-Promoter Nil Nil 2,50,000 2,50,000 1.96 Group 10. Ilyashbhai Dhobi Non-Promoter Nil Nil 6,30,000 6,30,000 4.94 Group 11. Sanjay Kumar Sharma Non-Promoter Nil Nil 3,00,000 3,00,000 2.35 Group 12. Pooja Chotia Non-Promoter Nil Nil 3,00,000 3,00,000 2.35 Group 13. Havish Suppliers LLP Non-Promoter Nil Nil 3,00,000 3,00,000 2.35 Group 14. Kailash Dhanuka HUF Non-Promoter Nil Nil 3,30,000 3,30,000 2.59 Group 15. Ruchika Dhanuka Non-Promoter Nil Nil 3,00,000 3,00,000 2.35 Group 16. Arpit Kabra Non-Promoter Nil Nil 6,30,000 6,30,000 4.94 Group 17. P. B. Films Limited Non-Promoter Nil Nil 6,30,000 6,30,000 4.94 Group 18. Kyan Investment & Trading Non-Promoter Nil Nil 6,30,000 6,30,000 4.94 Company Private Limited Group *Assuming full conversion of the Warrants Warrants are convertible into fully paid-up equity shares of the Company, in one or more tranches, at any time on or before the expiry of 18 (eighteen) months from the date of allotment and the unconverted Warrants shall lapse, and the amount paid by the Warrant holder on such Warrants shall stand forfeited. Information as required under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No.: SEBI/HO/CFD/CFD- PoD1/P/CIR/2023/123 dated July 13, 2023 and HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is enclosed as Annexure A. The aforesaid details is also available on the Company’s website at_https://wardwizardhealthcare.com/ Kindly take the same into your records. Thanking you, Yours’ faithfully, For Wardwizard Healthcare Limited CS Rajbala Kiroriwal Company Secretary & Compliance Officer Membership No. A51986 Enclosed: As above Annexure A Information as required under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No.: SEBI/HO/CFD/CFD- PoD1/P/CIR/2023/123 dated July 13, 2023 and HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026: Sr No. Particulars of event or information Details 1. Type of Securities proposed to be issued Fully convertible warrants 2. Type of Issuance Preferential Issue 3. Total number of Securities proposed to be issued or Issuance of upto 1,25,00,000 the total amount for which the Securities will be issued Warrants for an aggregate amount of upto ₹12,50,00,000/- (Rupees Twelve Crore Twenty- Five Lakhs Only) 4. Name and number of the Investor(s) Share Warrants: Sl Name of Investor 1. Yatin Sanjay Gupte 2. Sheetal Mandar Bhalerao 3. Ram Chander Sharma 4. Nitu Sharma 5. Ram Chander Sharma 6. Shyam Sunder Sharma 7. Hemlata Sharma 8. Shyam Sunder Sharma 9. Aakanksha Kabra 10. Ilyashbhai Dhobi 11. Sanjay Kumar Sharma 12. Pooja Chotia 13. Havish Suppliers LLP 14. Kailash Dhanuka HUF 15. Ruchika Dhanuka 16. Arpit Kabra 17. P. B. Films Limited 18. Kyan Investment & Trading Company Private Limited 5. Issue Price Preferential Allotment of Fully Convertible Warrants to be issued at par at Rs. 10/-, being determined by the Board in accordance with the provisions of Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. 6. In case of convertibles, Intimation on conversion of Each Warrant is convertible securities or on lapse of the tenure of the instrument. into 1 Equity Share and the conversion can be exercised at any time within a period of 18 months from the date of allotment, in one or more tranches, as the case may be and on such other terms and conditions as applicable. 7. Nature of Consideration (Whether cash Cash Consideration or consideration other than cash) 8. Use Proceeds The proceeds of the Preferential Issue shall be utilised for the growth and expansion initiatives, inter alia, including investment in promoter and promoter group entities, including but not limited to Wardwizard Medicare Private Limited, for the overall growth and expansion of the group companies; meeting working capital requirements; and for general corporate purposes The more detail regarding the use of the proceeds of the issue shall be provided in the explanatory statement attached to the notice of the ensuing Annual General Meeting For Wardwizard Healthcare Limited CS Rajbala Kiroriwal Company Secretary & Compliance Officer Membership No. A51986